Alexandra Safronova, MD is currently Head of Medical, Ever Neuro Pharma. Dr. Safronova earned her medical degree from Moscow Medical Academy cum laude. She completed her residency in internal medicine at Moscow Medical Academy, and fellowships in intensive care at Pirogov Medical University and endocrinology at the Russian Medical Postgraduate Academy. Before her pharmaceutical career, Dr. Safronova served as a staff physician in the Cardiology and Intensive Care Department at Medical Center of the Russian Academy of Science. Dr. Safronova started her career in the pharmaceutical industry in 1999 as Clinical Research Scientist at GlaxoSmithKline, then she worked as Manager of Clinical Operations at Quintiles (now IQVIA). In 2010 she joined Teva as Director of Clinical Research. Her primary task there was to set up Clinical Research Department from the scratch to support registration of new products and supervise global studies. Within two years Teva became #1 in clinical research in Russia. The company received 7 new market authorizations supported by the results of clinical program developed and executed by the department headed by Dr. Safronova.  In 2013 Dr Safonova focused on building Medical Affairs function from scratch as Medical Director of Russia and CIS, Teva Pharmaceutical. In 2015 -2018 she took position of Medical Director and Head of Medical Affairs Boehringer Ingelheim Russia. Dr. Safronova’s experience in multiple therapeutic areas includes Phases I-IV and diverse disciplines of medical affairs and product commercialization, such as leading office based and field-based medical teams (MSLs),life cycle management, PV/safety, Regulatory Affairs, Medical information, Patient Advocacy.